Annual CFI
$2800.00
+$5100.00+221.74%
December 31, 2023
Summary
- As of February 8, 2025, TENX annual cash flow from investing activities is $2800.00, with the most recent change of +$5100.00 (+221.74%) on December 31, 2023.
- During the last 3 years, TENX annual CFI has fallen by -$17.30 thousand (-86.07%).
- TENX annual CFI is now -99.99% below its all-time high of $22.21 million, reached on December 31, 2016.
Performance
TENX Cash From Investing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, TENX quarterly cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, TENX quarterly CFI has stayed the same.
- TENX quarterly CFI is now -100.00% below its all-time high of $12.38 million, reached on December 31, 2016.
Performance
TENX Quarterly CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFI
$0.00
$0.000.00%
September 30, 2024
Summary
- As of February 8, 2025, TENX TTM cash flow from investing activities is $0.00, unchanged on September 30, 2024.
- Over the past year, TENX TTM CFI has dropped by -$1600.00 (-100.00%).
- TENX TTM CFI is now -100.00% below its all-time high of $22.21 million, reached on December 31, 2016.
Performance
TENX TTM CFI Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Investing Formula
CFI = Cash Inflows from Investments − Cash Outflows for Investments
TENX Cash From Investing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +221.7% | 0.0% | -100.0% |
| 3 y3 years | -86.1% | -100.0% | -100.0% |
| 5 y5 years | -100.0% | -100.0% | -100.0% |
TENX Cash From Investing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -99.4% | +221.7% | -100.0% | +100.0% | -100.0% | +100.0% |
| 5 y | 5-year | -99.4% | +221.7% | -100.0% | +100.0% | -100.0% | +100.0% |
| alltime | all time | -100.0% | +100.0% | -100.0% | +100.0% | -100.0% | +100.0% |
Tenax Therapeutics Cash From Investing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jun 2024 | - | $0.00(0.0%) | $0.00(-100.0%) |
| Mar 2024 | - | $0.00(0.0%) | $1600.00(-42.9%) |
| Dec 2023 | $2800.00(-221.7%) | $0.00(0.0%) | $2800.00(-58.8%) |
| Sep 2023 | - | $0.00(-100.0%) | $6800.00(0.0%) |
| Jun 2023 | - | $1600.00(+33.3%) | $6800.00(+30.8%) |
| Mar 2023 | - | $1200.00(-70.0%) | $5200.00(-326.1%) |
| Dec 2022 | -$2300.00(-100.5%) | $4000.00(>+9900.0%) | -$2300.00(-71.3%) |
| Sep 2022 | - | $0.00(0.0%) | -$8000.00(-101.6%) |
| Jun 2022 | - | $0.00(-100.0%) | $503.50 K(+4.2%) |
| Mar 2022 | - | -$6300.00(+270.6%) | $483.20 K(+6.8%) |
| Dec 2021 | $452.60 K(+2151.7%) | -$1700.00(-100.3%) | $452.50 K(-1.1%) |
| Sep 2021 | - | $511.50 K(-2619.7%) | $457.70 K(-995.7%) |
| Jun 2021 | - | -$20.30 K(-45.1%) | -$51.10 K(+382.1%) |
| Mar 2021 | - | -$37.00 K(-1157.1%) | -$10.60 K(-152.7%) |
| Dec 2020 | $20.10 K(-1282.4%) | $3500.00(+29.6%) | $20.10 K(<-9900.0%) |
| Sep 2020 | - | $2700.00(-86.6%) | -$100.00(-100.5%) |
| Jun 2020 | - | $20.20 K(-420.6%) | $21.30 K(+2266.7%) |
| Mar 2020 | - | -$6300.00(-62.3%) | $900.00(-156.3%) |
| Dec 2019 | -$1700.00(-100.0%) | -$16.70 K(-169.3%) | -$1600.00(-100.1%) |
| Sep 2019 | - | $24.10 K(<-9900.0%) | $1.33 M(-42.4%) |
| Jun 2019 | - | -$200.00(-97.7%) | $2.30 M(-47.7%) |
| Mar 2019 | - | -$8800.00(-100.7%) | $4.40 M(-40.2%) |
| Dec 2018 | $7.35 M(+96.2%) | $1.31 M(+31.1%) | $7.35 M(+2.6%) |
| Sep 2018 | - | $1.00 M(-52.3%) | $7.17 M(+3.5%) |
| Jun 2018 | - | $2.10 M(-28.8%) | $6.92 M(+23.0%) |
| Mar 2018 | - | $2.95 M(+162.4%) | $5.63 M(+50.1%) |
| Dec 2017 | $3.75 M(-83.1%) | $1.12 M(+48.5%) | $3.75 M(-75.0%) |
| Sep 2017 | - | $756.10 K(-5.5%) | $15.01 M(-13.4%) |
| Jun 2017 | - | $800.50 K(-25.2%) | $17.32 M(-14.9%) |
| Mar 2017 | - | $1.07 M(-91.4%) | $20.35 M(-8.3%) |
| Dec 2016 | $22.21 M(+364.1%) | $12.38 M(+302.6%) | $22.21 M(+126.0%) |
| Sep 2016 | - | $3.08 M(-19.7%) | $9.83 M(-10.3%) |
| Jun 2016 | - | $3.83 M(+31.1%) | $10.95 M(+62.5%) |
| Mar 2016 | - | $2.92 M(-30.4%) | $6.74 M(+76.8%) |
| Dec 2015 | $4.78 M(-111.7%) | - | - |
| Oct 2015 | - | $4.20 M(-1202.3%) | $3.81 M(-175.3%) |
| Jul 2015 | - | -$380.90 K(+22.7%) | -$5.06 M(-87.1%) |
| Apr 2015 | -$40.93 M(>+9900.0%) | -$310.50 K(-118.6%) | -$39.26 M(+0.8%) |
| Mar 2015 | - | $1.67 M(-222.3%) | -$38.95 M(-4.2%) |
| Jan 2015 | - | -$1.37 M(-70.8%) | -$40.65 M(+3.4%) |
| Oct 2014 | - | -$4.67 M(-86.5%) | -$39.33 M(+13.4%) |
| Jul 2014 | - | -$34.58 M(>+9900.0%) | -$34.69 M(>+9900.0%) |
| Apr 2014 | -$147.00 K(-0.7%) | -$34.00 K(-23.1%) | -$147.10 K(-5.2%) |
| Jan 2014 | - | -$44.20 K(+23.8%) | -$155.20 K(+6.2%) |
| Oct 2013 | - | -$35.70 K(+7.5%) | -$146.20 K(-0.7%) |
| Jul 2013 | - | -$33.20 K(-21.1%) | -$147.20 K(-0.6%) |
| Apr 2013 | -$148.00 K(-43.3%) | -$42.10 K(+19.6%) | -$148.10 K(-7.4%) |
| Jan 2013 | - | -$35.20 K(-4.1%) | -$159.90 K(-6.2%) |
| Oct 2012 | - | -$36.70 K(+7.6%) | -$170.40 K(-18.3%) |
| Jul 2012 | - | -$34.10 K(-36.7%) | -$208.50 K(-20.1%) |
| Apr 2012 | -$261.10 K | -$53.90 K(+17.9%) | -$261.10 K(-13.1%) |
| Jan 2012 | - | -$45.70 K(-38.9%) | -$300.50 K(-18.4%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Oct 2011 | - | -$74.80 K(-13.7%) | -$368.10 K(-6.0%) |
| Jul 2011 | - | -$86.70 K(-7.1%) | -$391.50 K(-15.6%) |
| Apr 2011 | -$463.90 K(-14.4%) | -$93.30 K(-17.7%) | -$463.90 K(-12.4%) |
| Jan 2011 | - | -$113.30 K(+15.4%) | -$529.70 K(-5.8%) |
| Oct 2010 | - | -$98.20 K(-38.3%) | -$562.10 K(-8.5%) |
| Jul 2010 | - | -$159.10 K(0.0%) | -$614.10 K(+13.4%) |
| Apr 2010 | -$541.70 K(+47.5%) | -$159.10 K(+9.2%) | -$541.70 K(+10.6%) |
| Jan 2010 | - | -$145.70 K(-3.0%) | -$489.70 K(-4.1%) |
| Oct 2009 | - | -$150.20 K(+73.2%) | -$510.50 K(+21.5%) |
| Jul 2009 | - | -$86.70 K(-19.0%) | -$420.30 K(+14.4%) |
| Apr 2009 | -$367.30 K(+259.7%) | -$107.10 K(-35.7%) | -$367.30 K(+6.2%) |
| Jan 2009 | - | -$166.50 K(+177.5%) | -$346.00 K(+84.5%) |
| Oct 2008 | - | -$60.00 K(+78.0%) | -$187.50 K(+44.7%) |
| Jul 2008 | - | -$33.70 K(-60.7%) | -$129.60 K(+26.9%) |
| Apr 2008 | -$102.10 K(+429.0%) | -$85.80 K(+972.5%) | -$102.10 K(+418.3%) |
| Jan 2008 | - | -$8000.00(+281.0%) | -$19.70 K(+24.7%) |
| Oct 2007 | - | -$2100.00(-66.1%) | -$15.80 K(-20.2%) |
| Jul 2007 | - | -$6200.00(+82.4%) | -$19.80 K(+3.1%) |
| Apr 2007 | -$19.30 K(-65.7%) | -$3400.00(-17.1%) | -$19.20 K(+6.1%) |
| Jan 2007 | - | -$4100.00(-32.8%) | -$18.10 K(-44.0%) |
| Oct 2006 | - | -$6100.00(+8.9%) | -$32.30 K(-28.1%) |
| Jul 2006 | - | -$5600.00(+143.5%) | -$44.90 K(-20.1%) |
| Apr 2006 | -$56.20 K(-47.4%) | -$2300.00(-87.4%) | -$56.20 K(+3.1%) |
| Jan 2006 | - | -$18.30 K(-2.1%) | -$54.50 K(-11.1%) |
| Oct 2005 | - | -$18.70 K(+10.7%) | -$61.30 K(+26.1%) |
| Jul 2005 | - | -$16.90 K(+2716.7%) | -$48.60 K(-54.5%) |
| Apr 2005 | -$106.90 K(+1.9%) | -$600.00(-97.6%) | -$106.80 K(-4.6%) |
| Jan 2005 | - | -$25.10 K(+318.3%) | -$112.00 K(-29.9%) |
| Oct 2004 | - | -$6000.00(-92.0%) | -$159.70 K(-6.1%) |
| Jul 2004 | - | -$75.10 K(+1194.8%) | -$170.00 K(+62.1%) |
| Apr 2004 | -$104.90 K(+62.4%) | -$5800.00(-92.0%) | -$104.90 K(-1.7%) |
| Jan 2004 | - | -$72.80 K(+346.6%) | -$106.70 K(+157.7%) |
| Oct 2003 | - | -$16.30 K(+63.0%) | -$41.40 K(+10.7%) |
| Jul 2003 | - | -$10.00 K(+31.6%) | -$37.40 K(-42.1%) |
| Apr 2003 | -$64.60 K(-82.8%) | -$7600.00(+1.3%) | -$64.60 K(-107.1%) |
| Jan 2003 | - | -$7500.00(-39.0%) | $914.30 K(-533.9%) |
| Oct 2002 | - | -$12.30 K(-66.9%) | -$210.70 K(-17.4%) |
| Jul 2002 | - | -$37.20 K(-103.8%) | -$255.00 K(-32.3%) |
| Apr 2002 | -$376.50 K(+18.6%) | $971.30 K(-185.8%) | -$376.50 K(-74.1%) |
| Jan 2002 | - | -$1.13 M(+1900.9%) | -$1.45 M(+343.9%) |
| Oct 2001 | - | -$56.60 K(-64.3%) | -$327.50 K(-8.1%) |
| Jul 2001 | - | -$158.70 K(+49.6%) | -$356.50 K(+12.3%) |
| Apr 2001 | -$317.50 K(+510.6%) | -$106.10 K(+1639.3%) | -$317.40 K(+20.5%) |
| Jan 2001 | - | -$6100.00(-92.9%) | -$263.30 K(+2.4%) |
| Oct 2000 | - | -$85.60 K(-28.4%) | -$257.20 K(+49.9%) |
| Jul 2000 | - | -$119.60 K(+130.0%) | -$171.60 K(+230.0%) |
| Apr 2000 | -$52.00 K(-48.0%) | -$52.00 K(<-9900.0%) | -$52.00 K(<-9900.0%) |
| Jan 2000 | - | $0.00(0.0%) | $0.00(0.0%) |
| Oct 1999 | - | $0.00(0.0%) | $0.00(0.0%) |
| Jul 1999 | - | $0.00 | $0.00 |
| Apr 1999 | -$100.00 K(+98.4%) | - | - |
| Apr 1998 | -$50.40 K(+19.7%) | - | - |
| Apr 1997 | -$42.10 K(-22.2%) | - | - |
| Apr 1996 | -$54.10 K | - | - |
FAQ
- What is Tenax Therapeutics annual cash flow from investing activities?
- What is the all time high annual CFI for Tenax Therapeutics?
- What is Tenax Therapeutics annual CFI year-on-year change?
- What is Tenax Therapeutics quarterly cash flow from investing activities?
- What is the all time high quarterly CFI for Tenax Therapeutics?
- What is Tenax Therapeutics quarterly CFI year-on-year change?
- What is Tenax Therapeutics TTM cash flow from investing activities?
- What is the all time high TTM CFI for Tenax Therapeutics?
- What is Tenax Therapeutics TTM CFI year-on-year change?
What is Tenax Therapeutics annual cash flow from investing activities?
The current annual CFI of TENX is $2800.00
What is the all time high annual CFI for Tenax Therapeutics?
Tenax Therapeutics all-time high annual cash flow from investing activities is $22.21 M
What is Tenax Therapeutics annual CFI year-on-year change?
Over the past year, TENX annual cash flow from investing activities has changed by +$5100.00 (+221.74%)
What is Tenax Therapeutics quarterly cash flow from investing activities?
The current quarterly CFI of TENX is $0.00
What is the all time high quarterly CFI for Tenax Therapeutics?
Tenax Therapeutics all-time high quarterly cash flow from investing activities is $12.38 M
What is Tenax Therapeutics quarterly CFI year-on-year change?
Over the past year, TENX quarterly cash flow from investing activities has changed by $0.00 (0.00%)
What is Tenax Therapeutics TTM cash flow from investing activities?
The current TTM CFI of TENX is $0.00
What is the all time high TTM CFI for Tenax Therapeutics?
Tenax Therapeutics all-time high TTM cash flow from investing activities is $22.21 M
What is Tenax Therapeutics TTM CFI year-on-year change?
Over the past year, TENX TTM cash flow from investing activities has changed by -$1600.00 (-100.00%)